News

SenoRx is partnering with local distributors who have breast imaging and/or interventional radiology franchises in Austria, Belgium, England, Hong Kong, Ireland, Luxembourg, The Netherlands, Singapore, Switzerland and Taiwan.

Hologic will continue to trade on the Nasdaq Global Select Market under the symbol HOLX while Cytyc will become a wholly-owned subsidiary of Hologic. Under the terms of

One of the objectives of the exclusive licensing agreement is to evaluate the safety and efficacy of treating stroke patients with caffeinol, administered by intravenous infusion, in combination

Renvela is a next-generation version of Renagel (sevelamer hydrochloride), the most-prescribed phosphate binder in the US. Genzyme expects to launch Renvela for dialysis patients in the US during

Bioenvision shares have now ceased trading and the company will be delisted from Nasdaq. In total, 56% of Bioenvision’s issued and outstanding shares of common stock and preferred

DepoDur, which was developed by and licensed from Pacira Pharmaceuticals, utilizes Pacira’s DepoFoam technology and is a novel, single dose modified-release formulation of morphine. The approved indication in

The Menactra vaccine is the first and only quadrivalent conjugate vaccine licensed in the US for the prevention of meningococcal disease. Menactra vaccine offers protection against Neisseria meningitidis

The drug is currently awaiting FDA approval. Under the terms of the agreement, Solvay will provide sales support in the US, contribute to development and promotional expenses and

The Phase IIb trial was an in-clinic evaluation of tezampanel in patients suffering a single migraine attack, with or without aura. The clinical trial was designed as a